Table 1.
Baseline characteristics of the patients, n (%)
|
|
Overall (n = 256)
|
Conventional LLR (n = 150)
|
Novel LLR (n = 106)
|
P value
|
| Age, year | 62.88 ± 10.52 | 62.43 ± 11.07 | 63.52 ± 9.71 | 0.414 |
| Sex | 1.000 | |||
| Male | 130 (50.8) | 76 (50.7) | 54 (50.9) | |
| Female | 126 (49.2) | 74 (49.3) | 52 (49.1) | |
| Pathological types | 0.707 | |||
| HCC | 176 (68.8) | 105 (70.0) | 71 (67.0) | |
| ICC | 80 (31.2) | 45 (30.0) | 35 (33.0) | |
| BMI, kg/m2 | 23.77 ± 4.30 | 23.90 ± 4.29 | 23.59 ± 4.33 | 0.567 |
| Hepatitis B/C virus | 0.119 | |||
| B | 212 (82.8) | 130 (86.7) | 82 (77.4) | |
| C | 9 (3.5) | 5 (3.3) | 4 (3.8) | |
| None | 35 (13.7) | 15 (10.0) | 20 (18.9) | |
| Cirrhosis | 0.694 | |||
| No | 99 (38.7) | 56 (37.3) | 43 (40.6) | |
| Yes | 157 (61.3) | 94 (62.7) | 63 (59.4) | |
| Comorbidities | 0.729 | |||
| No | 118 (46.1) | 71 (47.3) | 47 (44.3) | |
| Yes | 138 (53.9) | 79 (52.7) | 59 (55.7) | |
| BCLC | < 0.001 | |||
| 0 | 22 (8.6) | 21 (14.0) | 1 (0.9) | |
| A | 230 (89.8) | 129 (86.0) | 101 (95.3) | |
| B | 2 (0.8) | 0 (0.0) | 2 (1.9) | |
| C | 2 (0.8) | 0 (0.0) | 2 (1.9) | |
| CNLC | 0.650 | |||
| 1A | 207 (80.9) | 119 (79.3) | 88 (83.0) | |
| 1B | 45 (17.6) | 29 (19.3) | 16 (15.1) | |
| 2A | 4 (1.6) | 2 (1.3) | 2 (1.9) | |
| ECOG | 0.222 | |||
| 0 | 247 (96.5) | 147 (98.0) | 100 (94.3) | |
| 1 | 9 (3.5) | 3 (2.0) | 6 (5.7) | |
| Child-Pugh grade | 0.757 | |||
| A | 249 (97.3) | 145 (96.7) | 104 (98.1) | |
| B | 7 (2.7) | 5 (3.3) | 2 (1.9) | |
| Preoperative ICG retention rate | 5.00 ± 2.06 | 3.57 ± 1.18 | 7.01 ± 1.14 | < 0.001 |
| Conversion therapy | 1.000 | |||
| No | 253 (98.8) | 148 (98.7) | 105 (99.1) | |
| Yes | 3 (1.2) | 2 (1.3) | 1 (0.9) |
LLR: Laparoscopic liver resection; HCC: Hepatocellular carcinoma; ICC: Intrahepatic cholangiocarcinoma; BMI: Body mass index; BCLC: Barcelona Clinic Liver Cancer; CNLC: Chinese liver cancer; ECOG: Eastern Cooperative Oncology Group; ICG: Indocyanine green.